MyFinsight
Home
Blog
About
Back
Income Statement
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
source: myfinsight.com
Comprehensive loss
-$128,319,000
(-95.87%↓ Y/Y)
Foreign currency
translation gain
$2,000
(-91.67%↓ Y/Y)
Interest income, net
$4,545,000
(-49.68%↓ Y/Y)
Realized gain on
investments
$30,000
Net loss
-$128,022,000
(-95.27%↓ Y/Y)
Unrealized (gain) loss on
investments
-$299,000
(-1250.00%↓ Y/Y)
Total other income,
net
$4,575,000
(-49.24%↓ Y/Y)
Loss from operations
-$132,597,000
(-77.81%↓ Y/Y)
Total operating
expenses
$132,597,000
(77.81%↑ Y/Y)
Research and development
$115,754,000
(92.43%↑ Y/Y)
General and
administrative
$16,843,000
(16.79%↑ Y/Y)
Back